{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T14:20:46Z","timestamp":1793370046538,"version":"4.5.0"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Critical Reviews in Oncology\/Hematology"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.critrevonc.2020.103006","type":"journal-article","created":{"date-parts":[[2020,5,22]],"date-time":"2020-05-22T11:44:14Z","timestamp":1590147854000},"page":"103006","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"C","title":["The role of cardio-protective agents in cardio-preservation in breast cancer patients receiving Anthracyclines \u00b1 Trastuzumab: a Meta-analysis of clinical studies"],"prefix":"10.1016","volume":"153","author":[{"given":"Hagar","family":"Elghazawy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2541-2055","authenticated-orcid":false,"given":"Bhanu Prasad","family":"Venkatesulu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivek","family":"Verma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bala","family":"Pushparaji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique J.","family":"Monlezun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantinos","family":"Marmagkiolis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cezar A.","family":"Iliescu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.critrevonc.2020.103006_bib0005","first-page":"394","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J.o Clin.o"},{"issue":"14","key":"10.1016\/j.critrevonc.2020.103006_bib0010","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1016\/S0959-8049(99)00217-8","article-title":"From Halsted to prevention and beyond: advances in the management of breast cancer during the twentieth century","volume":"35","author":"Fisher","year":"1999","journal-title":"Eur. J. Cancer."},{"issue":"3","key":"10.1016\/j.critrevonc.2020.103006_bib0015","doi-asserted-by":"crossref","first-page":"R64","DOI":"10.1186\/bcr2901","article-title":"Cardiovascular disease competes with breast cancer as the leading cause of death for older females diagnosed with breast cancer: a retrospective cohort study","volume":"13","author":"Patnaik","year":"2011","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.critrevonc.2020.103006_bib0020","first-page":"525","article-title":"Anthracycline associated cardiotoxicity in survivors of childhood cancer","volume":"94","author":"Lipshultz","year":"2008","journal-title":"Heart (British Cardiac Society)"},{"issue":"October (4)","key":"10.1016\/j.critrevonc.2020.103006_bib0025","doi-asserted-by":"crossref","first-page":"66","DOI":"10.3389\/fcvm.2017.00066","article-title":"Radiation-Induced Cardiovascular Disease: A Clinical Perspective","volume":"26","author":"Yusuf","year":"2017","journal-title":"Front Cardiovasc Med."},{"issue":"November (11)","key":"10.1016\/j.critrevonc.2020.103006_bib0030","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1038\/nrcardio.2015.133","article-title":"Cardiotoxicity of anticancer treatments","volume":"12","author":"Ewer","year":"2015","journal-title":"Nat. Rev. Cardiol."},{"issue":"7","key":"10.1016\/j.critrevonc.2020.103006_bib0035","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.2165\/00003495-200565070-00008","article-title":"Dexarazoxane","volume":"65","author":"Cvetkovic","year":"2005","journal-title":"Drugs"},{"issue":"December (23)","key":"10.1016\/j.critrevonc.2020.103006_bib0040","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.1161\/CIRCULATIONAHA.106.635144","article-title":"Prevention of High-Dose Chemotherapy\u2013Induced Cardiotoxicity in High-Risk Patients by Angiotensin-Converting Enzyme Inhibition","volume":"114","author":"Cardinale","year":"2006","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.critrevonc.2020.103006_bib0045","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1186\/2193-1801-2-198","article-title":"Long-term, up to 18 months, protective effects of the angiotensin II receptor blocker telmisartan on Epirubin-induced inflammation and oxidative stress assessed by serial strain rate","volume":"2","author":"Dess\u00ec","year":"2013","journal-title":"Springerplus"},{"issue":"4","key":"10.1016\/j.critrevonc.2020.103006_bib0050","first-page":"1052","article-title":"Can the epirubicin cardiotoxicity in cancer patients be prevented by angiotensin converting enzyme inhibitors?","volume":"18","author":"Radulescu","year":"2013","journal-title":"J. BUON."},{"issue":"8","key":"10.1016\/j.critrevonc.2020.103006_bib0055","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1001\/jamaoncol.2016.1726","article-title":"Angiotensin II\u2013Receptor Inhibition With Candesartan to Prevent Trastuzumab-Related Cardiotoxic Effects in Patients With Early Breast Cancer: A Randomized Clinical Trial","volume":"2","author":"Boekhout","year":"2016","journal-title":"JAMA Oncol."},{"issue":"April (4)","key":"10.1016\/j.critrevonc.2020.103006_bib0060","doi-asserted-by":"crossref","first-page":"270","DOI":"10.2459\/JCM.0000000000000232","article-title":"Chemotherapy cardiotoxicity: cardioprotective drugs and early identification of cardiac dysfunction","volume":"17","author":"Di Lisi","year":"2016","journal-title":"J. Cardiovasc. Med."},{"issue":"5","key":"10.1016\/j.critrevonc.2020.103006_bib0065","article-title":"208P: Prevention of cardiotoxicity in breast cancer patients: A randomized prospective study","volume":"28","author":"Elkhateeb","year":"2017","journal-title":"Abstract. Annals of Oncology."},{"issue":"130","key":"10.1016\/j.critrevonc.2020.103006_bib0070","article-title":"Effect of Enalapril on Preventing Anthracycline-Induced Cardiomyopathy","volume":"17","author":"Janbabai","year":"2017","journal-title":"Cardiovasc Toxicol."},{"issue":"March (8)","key":"10.1016\/j.critrevonc.2020.103006_bib0075","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1200\/JCO.2016.68.7830","article-title":"Multidisciplinary Approach to Novel Therapies in Cardio-Oncology Research (MANTICORE 101\u2013Breast): A Randomized Trial for the Prevention of Trastuzumab-Associated Cardiotoxicity","volume":"35","author":"Pituskin","year":"2017","journal-title":"J Clin Oncol."},{"issue":"20","key":"10.1016\/j.critrevonc.2020.103006_bib0080","first-page":"5","article-title":"P1650: Low body mass index and arterial hypotension as early predictors ofcardiotoxicity in patients with HER2 + breast cancer","author":"Vitsenya","year":"2018","journal-title":"Abstract. Eur J Heart Fail."},{"issue":"11","key":"10.1016\/j.critrevonc.2020.103006_bib0085","doi-asserted-by":"crossref","first-page":"2258","DOI":"10.1016\/j.jacc.2006.07.052","article-title":"Protective Effects of Carvedilol Against Anthracycline-Induced Cardiomyopathy","volume":"48","author":"Kalay","year":"2006","journal-title":"J Am Coll Cardiol."},{"issue":"2","key":"10.1016\/j.critrevonc.2020.103006_bib0090","doi-asserted-by":"crossref","first-page":"95","DOI":"10.15420\/ahhj.2011.9.2.95","article-title":"Protective effect of carvedilol in cardiomyopathy caused by anthracyclines in patients suffering from breast cancer and lymphoma","volume":"9","author":"Salehi","year":"2011","journal-title":"Am Heart Hosp J."},{"issue":"5","key":"10.1016\/j.critrevonc.2020.103006_bib0095","doi-asserted-by":"crossref","first-page":"2306","DOI":"10.1016\/j.ijcard.2012.06.023","article-title":"Protective effects of nebivolol against anthracycline-induced cardiomyopathy: A randomized control study","volume":"167","author":"Kaya","year":"2013","journal-title":"Int J Cardiol"},{"issue":"5","key":"10.1016\/j.critrevonc.2020.103006_bib0100","doi-asserted-by":"crossref","first-page":"509","DOI":"10.5603\/CJ.a2013.0150","article-title":"Effect of carvedilol on silent anthracycline-induced cardiotoxicity assessed by strain imaging: A prospective randomized controlled study with six-month follow-up","volume":"21","author":"Elitok","year":"2014","journal-title":"Cardiol J."},{"issue":"3","key":"10.1016\/j.critrevonc.2020.103006_bib0105","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1093\/ehjci\/jet159","article-title":"Use of speckle strain to assess left ventricular responses to cardiotoxic chemotherapy and cardioprotection","volume":"15","author":"Negishi","year":"2014","journal-title":"Eur Heart J Cardiovasc Imaging."},{"issue":"134","key":"10.1016\/j.critrevonc.2020.103006_bib0110","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1159\/000442722","article-title":"Carvedilol Administration Can Prevent Doxorubicin-Induced Cardiotoxicity: A Double-Blind Randomized Trial","author":"Beheshti","year":"2016","journal-title":"Cardiology"},{"issue":"21","key":"10.1016\/j.critrevonc.2020.103006_bib0115","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1093\/eurheartj\/ehw022","article-title":"Prevention of cardiac dysfunction during adjuvant breast cancer therapy (PRADA): a 2 \u00d7 2 factorial, randomized, placebo-controlled, double-blind clinical trial of candesartan and metoprolol","volume":"37","author":"Gulati","year":"2016","journal-title":"Eur Heart J."},{"key":"10.1016\/j.critrevonc.2020.103006_bib0120","article-title":"P3587:Acute anthracycline cardiotoxicity: carvedilol and omega-3 effects on cardiac and redox biomarkers","author":"Loza","year":"2016","journal-title":"Abstract. ESC Congress"},{"issue":"May (5)","key":"10.1016\/j.critrevonc.2020.103006_bib0125","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1097\/FJC.0000000000000470","article-title":"Cardioprotective Effects of Carvedilol in Inhibiting Doxorubicin-induced Cardiotoxicity","volume":"69","author":"Nabati","year":"2017","journal-title":"J Cardiovasc Pharmacol."},{"issue":"3","key":"10.1016\/j.critrevonc.2020.103006_bib0130","doi-asserted-by":"crossref","first-page":"S96","DOI":"10.1016\/j.ihj.2018.06.011","article-title":"Prophylactic use of carvedilol to prevent ventricular dysfunction in patients with cancer treated with doxorubicin","volume":"70","author":"Abuosa","year":"2018","journal-title":"Indian Heart Journal."},{"issue":"20","key":"10.1016\/j.critrevonc.2020.103006_bib0135","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1016\/j.jacc.2018.02.049","article-title":"Carvedilol for Prevention of Chemotherapy-Related Cardiotoxicity: The CECCY Trial","volume":"71","author":"Avila","year":"2018","journal-title":"J Am Coll of Cardiol"},{"key":"10.1016\/j.critrevonc.2020.103006_bib0140","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.2147\/CMAR.S166481","article-title":"Nebivolol effect on doxorubicin-induced cardiotoxicity in breast cancer","volume":"10","author":"Cochera","year":"2018","journal-title":"Cancer Manag Res."},{"issue":"136","key":"10.1016\/j.critrevonc.2020.103006_bib0145","first-page":"A20834","article-title":"A20834: Comparative Effect of Candesartan and Cavedilol in Prevention of Doxorubicin Induced Subclinical Cardiotoxicity","author":"Kim","year":"2017","journal-title":"Abstract. Circulation."},{"key":"10.1016\/j.critrevonc.2020.103006_bib0150","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/hr.2009.184","article-title":"Reinventing the ACE inhibitors: some old and new implications of ACE inhibition","volume":"33","author":"Hanif","year":"2010","journal-title":"Hypertens. Res."}],"container-title":["Critical Reviews in Oncology\/Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S104084282030144X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S104084282030144X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T19:40:06Z","timestamp":1760902806000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S104084282030144X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":30,"alternative-id":["S104084282030144X"],"URL":"https:\/\/doi.org\/10.1016\/j.critrevonc.2020.103006","relation":{},"ISSN":["1040-8428"],"issn-type":[{"value":"1040-8428","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The role of cardio-protective agents in cardio-preservation in breast cancer patients receiving Anthracyclines \u00b1 Trastuzumab: a Meta-analysis of clinical studies","name":"articletitle","label":"Article Title"},{"value":"Critical Reviews in Oncology\/Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.critrevonc.2020.103006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"103006"}}